Free Trial

Phathom Pharmaceuticals (PHAT) Institutional Ownership

Phathom Pharmaceuticals logo
$12.00 +0.12 (+1.01%)
Closing price 04:00 PM Eastern
Extended Trading
$11.99 -0.01 (-0.08%)
As of 07:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for Phathom Pharmaceuticals (NASDAQ:PHAT)

Current
Institutional Ownership
Percentage
99.01%
Number of
Institutional Buyers
(last 12 months)
89
Total
Institutional Inflows
(last 12 months)
$228.50M
Number of
Institutional Sellers
(last 12 months)
27
Total
Institutional Outflows
(last 12 months)
$57.78M
Get PHAT Insider Trade Alerts

Want to know when executives and insiders are buying or selling Phathom Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

PHAT Institutional Buying and Selling by Quarter

Phathom Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2025 Tower Research Capital LLC TRC 5,710$55K0.0%+58.3%0.008%
8/15/2025 Wasatch Advisors LP1,461,895$14.02M0.1%-14.1%2.061%
8/15/2025 Moore Capital Management LP600,000$5.75M0.1%N/A0.846%
8/15/2025 Frazier Life Sciences Management L.P.12,466,489$119.55M4.8%+23.3%17.573%
8/15/2025 Gilder Gagnon Howe & Co. LLC31,358$301K0.0%-24.6%0.044%
8/15/2025 BNP Paribas Financial Markets5,072$49K0.0%+71.9%0.007%
8/15/2025 Brevan Howard Capital Management LP27,834$267K0.0%N/A0.039%
8/15/2025 Birchview Capital LP25,000$240K0.2%N/A0.035%
8/15/2025 Bank of America Corp DE96,080$921K0.0%-43.6%0.135%
8/15/2025 683 Capital Management LLC2,105,000$20.19M1.3%+45.7%2.967%
8/15/2025 Ameriprise Financial Inc.180,851$1.73M0.0%N/A0.255%
8/14/2025 California State Teachers Retirement System2,889$28K0.0%-91.8%0.004%
8/14/2025 Raymond James Financial Inc.3,174$30K0.0%N/A0.004%
8/14/2025 The Manufacturers Life Insurance Company 15,826$152K0.0%+9.4%0.022%
8/14/2025 Nebula Research & Development LLC37,937$364K0.0%+31.6%0.053%
8/14/2025 Diadema Partners LP40,294$386K0.1%N/A0.057%
8/13/2025 Invesco Ltd.4,140,072$39.70M0.0%+13.4%5.836%
8/13/2025 Russell Investments Group Ltd.2,736$26K0.0%-93.5%0.004%
8/12/2025 XTX Topco Ltd14,330$137K0.0%-84.1%0.020%
8/12/2025 Ameritas Investment Partners Inc.4,311$41K0.0%+39.3%0.006%
8/12/2025 Rhumbline Advisers64,557$619K0.0%+13.8%0.091%
8/12/2025 Legal & General Group Plc4,087$39K0.0%-88.8%0.006%
8/12/2025 JPMorgan Chase & Co.138,516$1.33M0.0%+0.8%0.195%
8/12/2025 Entropy Technologies LP11,600$111K0.0%N/A0.016%
8/12/2025 Ensign Peak Advisors Inc2,519,972$24.17M0.0%+0.2%3.552%
8/11/2025 Persistent Asset Partners Ltd9,421$90K0.1%N/A0.013%
8/8/2025 Intech Investment Management LLC28,192$270K0.0%+31.2%0.040%
8/8/2025 Creative Planning57,264$549K0.0%-4.5%0.082%
8/8/2025 Geode Capital Management LLC1,069,927$10.26M0.0%+5.3%1.533%
8/7/2025 Simplify Asset Management Inc.521,935$5.01M0.3%-23.5%0.748%
8/6/2025 Savant Capital LLC11,771$113K0.0%N/A0.017%
7/31/2025 AlphaQuest LLC32,206$309K0.0%+2,127.2%0.046%
6/27/2025 Goldman Sachs Group Inc.187,874$1.18M0.0%-54.4%0.269%
5/16/2025 Woodline Partners LP751,692$4.71M0.0%-25.0%1.077%
5/16/2025 Goldman Sachs Group Inc.187,874$1.18M0.0%-54.4%0.269%
5/16/2025 Jacobs Levy Equity Management Inc.596,108$3.74M0.0%N/A0.854%
5/16/2025 AQR Capital Management LLC107,399$673K0.0%+508.2%0.154%
5/16/2025 683 Capital Management LLC1,445,000$9.06M0.6%+41.0%2.070%
5/15/2025 Propel Bio Management LLC1,134,927$7.12M8.3%+14.6%1.626%
5/15/2025 Trexquant Investment LP398,751$2.50M0.0%+5.3%0.571%
5/14/2025 Wellington Management Group LLP200,690$1.26M0.0%+47.6%0.287%
5/13/2025 Russell Investments Group Ltd.41,799$262K0.0%N/A0.060%
5/12/2025 Nuveen LLC101,520$637K0.0%N/A0.145%
5/12/2025 Invesco Ltd.3,650,812$22.89M0.0%-0.6%5.229%
5/9/2025 Charles Schwab Investment Management Inc.348,035$2.18M0.0%-1.4%0.499%
5/8/2025 US Bancorp DE23,763$149K0.0%+248.1%0.034%
5/8/2025 XTX Topco Ltd90,191$565K0.0%N/A0.129%
5/7/2025 Corton Capital Inc.18,384$115K0.4%N/A0.026%
5/5/2025 Jennison Associates LLC7,042,325$44.16M0.0%-0.3%10.111%
5/1/2025 CWM LLC7,384$46K0.0%+20,997.1%0.011%
4/29/2025 Bank of New York Mellon Corp114,535$718K0.0%+11.5%0.164%
4/7/2025 GAMMA Investing LLC4,558$29K0.0%+797.2%0.007%
4/2/2025 Kera Capital Partners Inc.29,849$187K0.1%+11.2%0.043%
3/24/2025 Wellington Management Group LLP135,995$1.10M0.0%-21.6%0.195%
2/17/2025 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC117,803$957K0.0%+20.2%0.172%
2/17/2025 Woodline Partners LP1,001,692$8.13M0.1%-61.1%1.465%
2/17/2025 Two Sigma Advisers LP133,700$1.09M0.0%N/A0.196%
2/17/2025 Two Sigma Investments LP485,790$3.95M0.0%+215.4%0.710%
2/17/2025 Tang Capital Management LLC500,000$4.06M0.3%N/A0.731%
2/17/2025 Rafferty Asset Management LLC11,113$90K0.0%N/A0.016%
2/17/2025 ProShare Advisors LLC14,289$116K0.0%+36.3%0.021%
2/17/2025Nuveen Asset Management LLC147,523$1.20M0.0%-4.4%0.216%
2/17/2025 Numerai GP LLC15,264$124K0.0%-69.1%0.022%
2/17/2025 Millennium Management LLC59,991$487K0.0%+82.2%0.088%
2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.22,149$180K0.0%+18.2%0.032%
2/17/2025 Ensign Peak Advisors Inc2,527,054$20.52M0.0%-2.1%3.696%
2/17/2025 Deutsche Bank AG30,213$245K0.0%+49.4%0.044%
2/17/2025 Cubist Systematic Strategies LLC282,553$2.29M0.0%N/A0.413%
2/17/2025 Catalys Pacific LLC1,167,114$9.48M8.2%+4.0%1.707%
2/17/2025 Brevan Howard Capital Management LP22,845$186K0.0%N/A0.033%
2/17/2025 Avidity Partners Management LP1,390,100$11.29M1.1%-23.0%2.033%
2/17/2025 Bayesian Capital Management LP14,900$121K0.0%N/A0.022%
2/17/2025 Bank of America Corp DE166,505$1.35M0.0%+60.4%0.243%
2/17/2025 BNP Paribas Financial Markets39,532$321K0.0%N/A0.058%
2/17/2025 683 Capital Management LLC1,025,000$8.32M0.5%+1.5%1.499%
2/14/2025 Oracle Investment Management Inc.145,064$1.18M0.6%-84.6%0.212%
2/14/2025 Northern Trust Corp397,964$3.23M0.0%+24.1%0.582%
2/14/2025 Tudor Investment Corp ET AL34,049$276K0.0%-6.4%0.050%
2/14/2025 Decheng Capital LLC694,254$5.64M1.2%-44.5%1.015%
2/14/2025 Propel Bio Management LLC989,927$8.04M8.0%+13.8%1.448%
2/14/2025 Virtus ETF Advisers LLC43,789$356K0.1%+45.6%0.064%
2/14/2025 Gilder Gagnon Howe & Co. LLC41,610$338K0.0%-97.4%0.061%
2/14/2025 Nebula Research & Development LLC20,963$170K0.0%N/A0.031%
2/14/2025 Price T Rowe Associates Inc. MD25,641$209K0.0%+21.8%0.037%
2/14/2025 Dark Forest Capital Management LP32,029$260K0.0%N/A0.047%
2/14/2025 MetLife Investment Management LLC24,366$198K0.0%+28.0%0.036%
2/13/2025 Canada Pension Plan Investment Board15,400$125K0.0%N/A0.023%
2/13/2025 Marshall Wace LLP98,068$796K0.0%N/A0.143%
2/13/2025 Wasatch Advisors LP1,558,928$12.66M0.1%+531.3%2.280%
2/13/2025 Barclays PLC76,463$621K0.0%+32.3%0.112%
2/13/2025Summit Financial Wealth Advisors LLC68,125$553K0.1%+134.7%0.100%
2/13/2025 Raymond James Financial Inc.455,837$3.70M0.0%N/A0.667%
2/13/2025 Capula Management Ltd16,083$131K0.0%N/A0.024%
2/13/2025 Invesco Ltd.3,671,386$29.81M0.0%-10.4%5.369%
2/13/2025 Aristides Capital LLC25,200$205K0.0%N/A0.037%
2/13/2025 Wells Fargo & Company MN25,516$207K0.0%+41.3%0.037%
2/12/2025 Trexquant Investment LP378,637$3.08M0.0%N/A0.554%
2/12/2025 Geode Capital Management LLC1,018,495$8.27M0.0%+18.0%1.489%
2/12/2025 Alliancebernstein L.P.45,590$370K0.0%-9.0%0.067%
2/12/2025 Wellington Management Group LLP135,995$1.10M0.0%-21.6%0.199%
(Data available from 1/1/2016 forward)

PHAT Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of PHAT shares?

During the previous two years, 126 institutional investors and hedge funds held shares of Phathom Pharmaceuticals. The most heavily invested institutionals were Frazier Life Sciences Management L.P. ($119.55M), Medicxi Ventures Management Jersey Ltd ($79.27M), Jennison Associates LLC ($44.16M), Invesco Ltd. ($39.70M), Portolan Capital Management LLC ($30.74M), Checkpoint Capital L.P. ($27.20M), and Ensign Peak Advisors Inc ($24.17M).Learn more on Phathom Pharmaceuticals' institutional investors.

What percentage of Phathom Pharmaceuticals' stock is owned by institutional investors?

99.01% of Phathom Pharmaceuticals' stock is owned by institutional investors. Learn more on PHAT's institutional investor holdings.

Which institutional investors have been buying Phathom Pharmaceuticals' stock?

Of the 110 institutional investors that purchased Phathom Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Jennison Associates LLC ($5.95M), Medicxi Ventures Management Jersey Ltd ($3.70M), Frazier Life Sciences Management L.P. ($2.36M), Wasatch Advisors LP ($1.56M), FMR LLC ($1.30M), 683 Capital Management LLC ($1.10M), and Raymond James Financial Inc. ($914.85K).

How much institutional buying is happening at Phathom Pharmaceuticals?

Institutional investors have bought a total of 19,345,570 shares in the last 24 months. This purchase volume represents approximately $228.50M in transactions.

Which of Phathom Pharmaceuticals' major shareholders have been selling company stock?

Of the 27 institutional investors that sold Phathom Pharmaceuticals' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Woodline Partners LP ($1.82M), Gilder Gagnon Howe & Co. LLC ($1.59M), Oracle Investment Management Inc. ($797.12K), Decheng Capital LLC ($555.75K), Goldman Sachs Group Inc. ($448.78K), Invesco Ltd. ($445.95K), and Avidity Partners Management LP ($414.39K).

How much institutional selling is happening at Phathom Pharmaceuticals?

Institutional investors have sold a total of 7,047,909 shares in the last 24 months. This volume of shares sold represents approximately $57.78M in transactions.



This page (NASDAQ:PHAT) was last updated on 9/4/2025 by MarketBeat.com Staff
From Our Partners